End of high-dose chemotherapy for high-risk breast cancer patients?

Journal of the National Cancer Institute

Volumn 100, Issue 9, 2008, Pages 618-619

  Tuma, Rabiya S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; BREAST TUMOR; CHEMISTRY; DOSE RESPONSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; META ANALYSIS; MORTALITY; NOTE; PATHOLOGY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; META-ANALYSIS AS TOPIC; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; UNITED STATES;

EID: 44049097966     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn143     Document Type: Note

References (0)